Karuna Therapeutics logo

Karuna Therapeutics

ID: 5833812

Karuna Therapeutics is a schizophrenia treatment founded in 2009 by Andrew Miller.

3

Funding Rounds

$148.0m

Money raised

Overview

Karuna Therapeutics is a schizophrenia treatment founded in 2009 by Andrew Miller.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company Karuna Therapeutics has raised a total of $80m in funding over 3 rounds.

Key Insights:

  • Karuna Therapeutics , April 2019: $12m
  • Karuna Therapeutics Series B round, March 2019: $68m
  • Karuna Therapeutics Inc funding round, March 2019: $68m

Industries

Karuna Therapeutics is active in the following industries: